| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0272d70c9ba3abebfdf08dc6b96f1120 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d0f794c1315d5b5ef202ee1a9a4f425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b23bcb85025664ef0045fc4a5ab8a8 |
| publicationDate |
2019-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190134094-A |
| titleOfInvention |
A pharmaceutical composition for preventing or treating a human cytomegalovirus disease comprising a gamma secretase inhibitor, and a method for screening a therapeutic agent for a human cytomegalovirus disease using gamma secretase |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating human cytomegalovirus infection disease comprising a gamma secretase inhibitor, and to a method for screening a human cytomegalovirus infection disease therapeutic agent using gamma secretase, and an Alzheimer's therapeutic agent or an anticancer agent. By identifying inhibitors of various gamma secretase enzymes developed for the purpose of inhibiting the proliferation of human cytomegalovirus, this suggests the possibility of development as a new therapeutic agent for human cytomegalovirus infection. It is expected to be used as an antiviral drug against human cytomegalovirus, which causes cancer and even the death of a weakened person. |
| priorityDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |